乳房重建中植入物体积与乳房切除标本重量的匹配问题
这项多中心回顾性队列研究纳入1031例患者共1617例乳房切除术,评估保留乳头乳房切除术联合即刻植入物重建时,植入物体积与乳房切除标本重量之间的容积不匹配对术后并发症的影响。容积不匹配≥78与并发症增加相关,包括感染、血清肿及因感染取出植入物,多因素回归显示容积不匹配为任意并发症的显著预测因素。
要点
- 容积不匹配≥78时任意并发症发生率14.6% vs 6.4%(P<0.0001)。
- 容积不匹配≥78时感染4.5% vs 1.6%(P=0.01),血清肿6.9% vs 1.9%(P<0.0001)。
- 多因素回归中容积不匹配OR 1.9(95%CI 1.0-3.4),P=0.043。
核心结论
- 植入物体积与乳房切除标本重量之间较大的容积不匹配是术后并发症(包括因感染取出植入物)的显著预测因素。
- 作者认为,了解这一点后,外科医生可选择使植入物体积与乳房切除标本重量更均匀匹配、选择保留皮肤的乳房切除术或考虑减少死腔的手术技术。
研究设计与样本
- 多中心回顾性队列研究,纳入接受保留乳头乳房切除术联合即刻植入物重建的患者。
- 共1617例乳房重建,来自1031例患者;平均随访25.3个月(±15.2)。
- 采用受试者工作特征曲线分析和多因素回归分析评估容积不匹配[乳房切除标本重量(g)减去植入物体积(mL)]对术后并发症的影响。
主要发现
- 平均乳房切除标本重量442.6 g(±219.1),平均植入物体积403.2 mL(±152.0),平均容积不匹配37.1(±108.2)。
- 总并发症率为8.3%。
- 在控制乳房切除标本重量和植入物体积后,容积不匹配≥78与并发症增加相关:任意并发症14.6% vs 6.4%(P<0.0001),因感染取出植入物2.9% vs 1.1%(P=0.05),感染4.5% vs 1.6%(P=0.01),血清肿6.9% vs 1.9%(P<0.0001)。
- 多因素回归分析显示,容积不匹配[OR 1.9(95%CI 1.0-3.4),P=0.043]、吸烟和年龄是任意并发症的显著预测因素。
关键数值与推荐
- 容积不匹配定义为乳房切除标本重量(g)减去植入物体积(mL)。
- 容积不匹配≥78为与并发症增加相关的阈值。
临床怎么用
- 作者认为,外科医生可选择使植入物体积与乳房切除标本重量更均匀匹配,选择保留皮肤的乳房切除术,或考虑减少死腔的手术技术。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: During nipple-sparing mastectomy with direct-to-implant based breast reconstruction, if the size of the chosen implant is smaller than the mastectomy specimen, a volumetric mismatch occurs creating dead space. This study evaluates the effect of volumetric mismatch between chosen implant size and mastectomy weight on postoperative complications after breast reconstruction. METHODS: A multicenter retrospective cohort study was conducted on patients undergoing nipple-sparing mastectomy with direct-to-implant based breast reconstruction. The effect of volumetric mismatch [mastectomy weight (g) - implant size (mL)] on postoperative complications were evaluated using receiver operating characteristic analysis and multivariable regression analyses. RESULTS: A total of 1617 breast reconstructions were performed in 1031 patients. The mean mastectomy weight was 442.6 g (±219.1), the mean implant size was 403.2 mL (±152.0) and the mean volumetric mismatch was 37.1 (±108.2). The mean follow-up was 25.3 months (±15.2). Total complication rate was 8.3%. A volumetric mismatch of ≥78 was associated with increased complications when controlled for mastectomy weight and implant size, with higher rates of any complication (14.6% vs 6.4%, P < 0.0001), explantation due to infection (2.9% vs 1.1%, P = 0.05), infection (4.5% vs 1.6%, P = 0.01), and seroma (6.9% vs 1.9%, P < 0.0001). On multivariable regression for any complication, volumetric mismatch [odds ratio 1.9 (95% CI 1.0-3.4) P = 0.043], smoking and age were significant predictors. CONCLUSIONS: A greater mismatch between implant size and mastectomy weight was a significant predictor of postoperative complications, including explantation. Knowing this, surgeons may choose to match implant size more evenly to mastectomy weight, opt for skin sparing mastectomies or consider operative techniques to minimize dead space.
引用
- Carruthers KH, Remy K, DePamphilis MA, et al. Implant Size Versus Mastectomy Weight in Breast Reconstruction: Does Matching Matter? Ann Plast Surg. 2025. PMID: 40084991. doi:10.1097/SAP.0000000000004309
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。